載入...
Chronic myeloid leukemia: sequencing of TKI therapies
Multiple tyrosine kinase inhibitors (TKIs) are available for managing patients with chronic myeloid leukemia. Although most patients have a favorable outcome with their initial therapy, whether imatinib or a second-generation TKI was used, some will require subsequent use of one or more different TK...
Na minha lista:
| 發表在: | Hematology Am Soc Hematol Educ Program |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society of Hematology
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6142480/ https://ncbi.nlm.nih.gov/pubmed/27913476 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|